PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.

    Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.

    If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.

    Filter results by:

    Results 81-82 of 82

    January 05, 2012 Drug Approval:

    Eylea(TM)

    Regeneron

    January 05, 2012 Drug Alert: Important Drug Warning

    ARCAPTA(TM) NEOHALER(TM) (indacaterol inhalation powder)

    Novartis Pharmaceuticals Corporation

    Results 81-82 of 82